NCT02864992 2025-12-23Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)EMD SeronoPhase 2 Active not recruiting337 enrolled 13 charts 2 FDA
NCT05812027 2025-11-17A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsTScan Therapeutics, Inc.Active not recruiting1,150 enrolled
NCT05585320 2025-09-02A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsImmuneering CorporationPhase 1/2 Active not recruiting209 enrolled
NCT02664935 2025-05-21National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerUniversity of BirminghamPhase 2 Active not recruiting423 enrolled
NCT04660929 2024-12-18CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsCarisma Therapeutics IncPhase 1 Active not recruiting48 enrolled
NCT05128487 2024-11-25A Study of NDI 1150-101 in Patients With Solid TumorsNimbus TherapeuticsPhase 1/2 Active not recruiting106 enrolled
NCT04544748 2024-03-06A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesAO GENERIUMPhase 1 Active not recruiting48 enrolled
NCT03132922 2024-01-22MAGE-A4ᶜ¹º³²T for Multi-TumorAdaptimmunePhase 1 Active not recruiting71 enrolled